in order to assess the value of the various atrial pacing techniques employed to evaluate the anterograde conduction of the accessory pathway and the effect of antiarrhythmic agents in wolff-parkinson-white syndrome , transesophageal atrial pacing was performed in 12 patients before and during treatment with oral flecainide acetate in doses of 200 mg per day .
C0003195
antiarrhythmic agents
C0086303
flecainide acetate